(Q34129781)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20686478%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

review article

1 reference

title

Prescription drug abuse: insight into the epidemic (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20686478%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1 reference

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20686478%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

author name string

S H Hernandez

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20686478%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

language of work or name

English

0 references

publication date

4 August 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20686478%20AND%20SRC:MED&resulttype=core&format=json

Clinical Pharmacology & Therapeutics

9 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20686478%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

volume

88

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20686478%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20686478%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

page(s)

307-317

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20686478%20AND%20SRC:MED&resulttype=core&format=json

Trends in prescription drug abuse and dependence, co-occurrence with other substance use disorders, and treatment utilization: results from two national surveys.

9 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.154

Coming to terms with the nonmedical use of prescription medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.154

Misperceptions of non-medical prescription drug use: a web survey of college students.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.154

Stimulant medication use, misuse, and abuse in an undergraduate and graduate student sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.154

Maternal hypothyroidism and cognitive development of the offspring

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.154

Comparing heroin users and prescription opioid users in a Canadian multi-site population of illicit opioid users

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.154

Sources of prescription drugs for illicit use

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.154

Trends in abuse of Oxycontin and other opioid analgesics in the United States: 2002-2004

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.154

Urine drug screening: practical guide for clinicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.154

Urine testing for norcodeine, norhydrocodone, and noroxycodone facilitates interpretation and reduces false negatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.154

Estimated costs of prescription opioid analgesic abuse in the United States in 2001: a societal perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.154

What constitutes prescription drug misuse? Problems and pitfalls of current conceptualizations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.154

College on Problems of Drug Dependence taskforce on prescription opioid non-medical use and abuse: position statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.154

Patterns of abuse among unintentional pharmaceutical overdose fatalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.154

A comparison of drug overdose deaths involving methadone and other opioid analgesics in West Virginia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.154

Blood-Brain Barrier: Penetration of Morphine, Codeine, Heroin, and Methadone after Carotid Injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.154

The dopamine-containing neuron: maestro or simple musician in the orchestra of addiction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.154

The relative abuse liability of oral oxycodone, hydrocodone and hydromorphone assessed in prescription opioid abusers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.154

Complications of intranasal prescription narcotic abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.154

Palatal perforation associated with intranasal prescription narcotic abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.154

Pulmonary microcrystalline cellulose deposition from intravenous injection of oral medication in a patient receiving parenteral nutrition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.154

CYP2D6 and CYP3A4 involvement in the primary oxidative metabolism of hydrocodone by human liver microsomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.154

Mu receptor binding of some commonly used opioids and their metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.154

Prescribing of opioid analgesics and related mortality before and after the introduction of long-acting oxycodone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.154

Quantitative contribution of CYP2D6 and CYP3A to oxycodone metabolism in human liver and intestinal microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.154

Pharmacokinetics and pharmacodynamics of oxycodone when given intravenously and rectally to adult patients with cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.154

Interindividual variability of the clinical pharmacokinetics of methadone: implications for the treatment of opioid dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.154

Stereoselective metabolism of methadone N-demethylation by cytochrome P4502B6 and 2C19.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.154

Involvement of CYP3A4, CYP2C8, and CYP2D6 in the metabolism of (R)- and (S)-methadone in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.154

Comparative oxycodone pharmacokinetics in humans after intravenous, oral, and rectal administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.154

Intravenous injection of pharmaceutical tablets presenting as multiple pulmonary nodules and declining pulmonary function in an adolescent with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.154

7 January 2021

Pulmonary embolization of microcrystalline cellulose in a lung transplant recipient

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.154

7 January 2021

Pharmacokinetic-pharmacodynamic relationships of controlled-release oxycodone

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.154

7 January 2021

Involvement of cytochrome P450 3A4 enzyme in the N-demethylation of methadone in human liver microsomes

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.154

7 January 2021